{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:13:21Z","timestamp":1793506401336,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13550-w","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:24:36Z","timestamp":1779121476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evolution of resistance patterns in Enterobacterales according to urinary tract infection diagnosis: implications for empirical therapy in a French emergency department"],"prefix":"10.1186","volume":"26","author":[{"given":"Alassane","family":"Sarr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Segla Robert Credo","family":"Houngnandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matta Antoun","family":"Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannougbo Nestor","family":"Djiholisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samba","family":"Tounkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen Trang","family":"Nghiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximin","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Strazzulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Diamantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"5","key":"13550_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269\u201384. https:\/\/doi.org\/10.1038\/nrmicro3432.","journal-title":"Nat Rev Microbiol"},{"key":"13550_CR2","unstructured":"Antimicrobial resistance surveillance in. Europe 2023\u2009\u2013\u20092021 data [Internet]. 2023 [cited 2025 Sep 3]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/antimicrobial-resistance-surveillance-europe-2023-2021-data*"},{"issue":"5","key":"13550_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.medmal.2018.03.005","volume":"48","author":"F Caron","year":"2018","unstructured":"Caron F, Galperine T, Flateau C, Azria R, Bonacorsi S, Bruy\u00e8re F, et al. Practice guidelines for the management of adult community-acquired urinary tract infections. Med Mal Infect. 2018;48(5):327\u201358. https:\/\/doi.org\/10.1016\/j.medmal.2018.03.005.","journal-title":"Med Mal Infect"},{"issue":"10","key":"13550_CR4","doi-asserted-by":"publisher","first-page":"e00862","DOI":"10.1128\/AAC.00862-20","volume":"64","author":"AE Stapleton","year":"2020","unstructured":"Stapleton AE, Wagenlehner FME, Mulgirigama A, Twynholm M. Escherichia coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection in Women: a Systematic Review. Antimicrob Agents Chemother. 2020;64(10):e00862\u201320. https:\/\/doi.org\/10.1128\/AAC.00862-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"13550_CR5","unstructured":"The European committee on antimicrobial susceptibility testing [Internet]. Breakpoint tables for interpretation of MICs and zone diameters, Version 11.0. 2021 [cited April 30, 2025]. Available from: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_11.0_Breakpoint_Tables.pdf."},{"key":"13550_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jgar.2020.10.020","volume":"23","author":"IA Critchley","year":"2020","unstructured":"Critchley IA, Cotroneo N, Pucci MJ, Jain A, Mendes RE. Resistance among urinary tract pathogens collected in Europe during 2018. J Glob Antimicrob Resist. 2020;23:439\u201344. https:\/\/doi.org\/10.1016\/j.jgar.2020.10.020.","journal-title":"J Glob Antimicrob Resist"},{"key":"13550_CR7","doi-asserted-by":"publisher","unstructured":"Fernandez M, Gavaghan MB, Al-Taie A, Stone G, Kotb REM. 2826. Epidemiology of extended spectrum beta-lactamase (ESBL)-producing enterobacterales and antimicrobial resistance in urinary tract infection (UTI) and acute pyelonephritis (AP). Open Forum Infect Dis. 2023;10(2). https:\/\/doi.org\/10.1093\/ofid\/ofad500.2437.ofad500.2437.","DOI":"10.1093\/ofid\/ofad500.2437.ofad500.2437"},{"issue":"1","key":"13550_CR8","doi-asserted-by":"publisher","first-page":"100121","DOI":"10.1016\/j.infpip.2021.100121","volume":"3","author":"LM Smith","year":"2021","unstructured":"Smith LM, Ahern JW. Establishing Antibiotic Stewardship Programs in Rural Hospitals to Decrease Fluoroquinolone Prescribing: The Vermont Experience. Infect Prev Pract. 2021;3(1):100121. https:\/\/doi.org\/10.1016\/j.infpip.2021.100121.","journal-title":"Infect Prev Pract"},{"issue":"5","key":"13550_CR9","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103\u201320. https:\/\/doi.org\/10.1093\/cid\/ciq257.","journal-title":"Clin Infect Dis"},{"key":"13550_CR10","unstructured":"World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report: 2022 [Internet]. Geneva: WHO. 2022 [cited 2023 Nov 15]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240062702"},{"issue":"9","key":"13550_CR11","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.jamda.2020.01.111","volume":"21","author":"A Strazzulla","year":"2020","unstructured":"Strazzulla A, Bokobza S, Ombandza E, Kherallah K, Hommel S, Draidi R, et al. Impact of an Antimicrobial Stewardship Program on Resistance to Fluoroquinolones of Urinary Enterobacteriaceae Isolated From Nursing Home Residents: A Retrospective Cohort Study. J Am Med Dir Assoc. 2020;21(9):1322\u20136. https:\/\/doi.org\/10.1016\/j.jamda.2020.01.111.","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"13550_CR12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ijantimicag.2018.12.001","volume":"53","author":"S Abbara","year":"2019","unstructured":"Abbara S, Pitsch A, Jochmans S, Hodjat K, Cherrier P, Monchi M, et al. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit. Int J Antimicrob Agents. 2019;53(4):416\u201322. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.12.001.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"13550_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","volume":"10","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis. 2010;10(1):43\u201350. https:\/\/doi.org\/10.1016\/S1473-3099(09)70325-1.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"13550_CR14","doi-asserted-by":"publisher","first-page":"105123","DOI":"10.1016\/j.idnow.2025.105123","volume":"55","author":"S Reissier","year":"2025","unstructured":"Reissier S, Penven M, Amara M, Dortet L, Riverain E, Caspar Y, et al. GMC study group. Bacterial epidemiology and antibiotic resistance rates in male urinary tract infections in France, 2019\u20132023. Infect Dis Now. 2025;55(7):105123. https:\/\/doi.org\/10.1016\/j.idnow.2025.105123.","journal-title":"Infect Dis Now"},{"key":"13550_CR15","unstructured":"Lemenand O, Thibaut S, Co\u00ebffic T, Caillon J, Birgand G. R\u00e9sistance aux c\u00e9phalosporines de 3e g\u00e9n\u00e9ration, aux carbap\u00e9n\u00e8mes et aux fluoroquinolones des isolats urinaires de Escherichia coli en soins de ville: tendances 2017\u20132021 en France. Bull \u00c9pid\u00e9miol Hebd. 2023;(22\u20133):458\u201364. http:\/\/beh.santepubliquefrance.fr\/beh\/2023\/22-23\/2023_22-23_2.html"},{"key":"13550_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jgar.2021.02.032","volume":"25","author":"C Loras","year":"2021","unstructured":"Loras C, Gonz\u00e1lez-Prieto A, P\u00e9rez-V\u00e1zquez M, Bautista V, \u00c1vila A, Sola Campoy P, et al. Prevalence, detection and characterisation of fosfomycin-resistant Escherichia coli strains carrying fosA genes in Community of Madrid, Spain. J Glob Antimicrob Resist. 2021;25:137\u201341. https:\/\/doi.org\/10.1016\/j.jgar.2021.02.032.","journal-title":"J Glob Antimicrob Resist"},{"issue":"3","key":"13550_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1128\/CMR.00125-13","volume":"27","author":"MH Nicolas-Chanoine","year":"2014","unstructured":"Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27(3):543\u201374. https:\/\/doi.org\/10.1128\/CMR.00125-13.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"13550_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.cger.2016.03.002","volume":"32","author":"LE Nicolle","year":"2016","unstructured":"Nicolle LE. Urinary Tract Infections in the Older Adult. Clin Geriatr Med. 2016;32(3):523\u201338. https:\/\/doi.org\/10.1016\/j.cger.2016.03.002. Epub 2016 Apr 18. PMID: 27394021.","journal-title":"Clin Geriatr Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13550-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13550-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:03:06Z","timestamp":1784041386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13550-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13550"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13550-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study of routine clinical practice data was conducted in accordance with French law (Public Health Code Article R.1121-1-1) which states that such research does not qualify as \u201cresearch involving human persons\u201d under the Jard\u00e9 law framework and therefore does not require formal approval by an Institutional Review Board. The need for individual informed consent was waived for the same reason. The data processing protocol for this study was declared to\/reviewed by our institution\u2019s Data Protection Officer (DPO). The study was conducted in full compliance with the principles of the Declaration of Helsinki and the EU General Data Protection Regulation (GDPR 2016\/679). All data were fully anonymized before analysis.\u201d","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1310"}}